ITGR: Integer Holdings Corporation Stock

by  •  • Comments Off on ITGR: Integer Holdings Corporation Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 4,237.72
Enterprise Value ($M) 5,444.98
Book Value ($M) 1,606.70
Book Value / Share 46.05
Price / Book 2.64
NCAV ($M) -988.80
NCAV / Share -28.34
Price / NCAV -4.29

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.05

Liquidity (mrq)
Quick Ratio 2.14
Current Ratio 3.40

Balance Sheet (mrq) ($M)
Current Assets 702.20
Assets 3,297.70
Liabilities 1,691.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,716.60
Operating Income 226.63
Net Income 119.90
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 205.21
Cash from Investing -195.41
Cash from Financing 13.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-15 13G/A Dimensional Fund Advisors Lp 4.60 -9.52

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 28, 2025 ☐ TRANSITION REPORT P
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHAN
2024-10-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2024 ☐ TRANSITION REPO
2024-07-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2024 ☐ TRANSITION REPORT PU

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-25 145,573 377,021 38.61
2025-04-24 356,835 1,175,877 30.35
2025-04-23 207,350 505,609 41.01
2025-04-22 83,131 234,349 35.47

(click for more detail)

Similar Companies
GMED – Globus Medical, Inc. HAE – Haemonetics Corporation
INSP – Inspire Medical Systems, Inc. MDT – Medtronic plc
MMM – 3M Company


Financial data and stock pages provided by
Fintel.io